RT @RichardPAConway: Singh @NamrataRheum et al. 27,421 RA patients, 8225 on b/tsDMARD. b/tsDMARDs did not increase risk
Tweet Content
Singh @NamrataRheum et al. 27,421 RA patients, 8225 on b/tsDMARD. b/tsDMARDs did not increase risk of lymphoma. IR 1.68/1000PY (95% CI 1.5-1.9) on csDMARD vs IR 1.73/1000PY (95%CI 1.4-2.1) on b/tsDMARD. @RheumNow #ACR22 Abstr#1210 https://t.co/3Uvz3mvsGM https://t.co/6k3Vqb21KF
Links
Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs an…
https://acrabstracts.org/abstract/use-of-biologic-or-targeted-synthetic-disease…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off